Tag: Hematopoietic stem-cell transplantation
#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)
Check out the original article from the Lancet Haematology here.
Quick Take: Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide
Umbilical cord blood (UCB) is a rich source of stem cells for transplantation in patients with hematologic malignancies. However, its ...
![Engineered stem cells mitigate liver damage caused by radiation [PreClinical]](https://2minutemedicine-wpengine.netdna-ssl.com/wp-content/uploads/2014/12/Human_embryonic_stem_cells-350x250.png)
2 Minute Medicine Rewind December 11, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer The risk of venous thromboembolism (VTE) is significantly increased in patients ...
Hematopoietic stem-cell transplantation may increase risk of fractures
1. In a retrospective review of over 7600 patients who previously underwent hematopoietic stem-cell transplantation, there was a significantly increased incidence of fractures ...
PTX3 gene deficiency may increase the risk of invasive aspergillosis in transplant patients
Image: PD 1. Hematopoeitic stem-cell transplant (HSCT) patients who received donor cells with a PTX3 haplotype of h2/h2 had an ...
Cord colitis syndrome found to have a novel infectious etiology
Image: PD 1. The genome of a novel bacterium Bradyrhizobium enterica was discovered via gene sequencing in patients with cord ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.